Introduction
Candida is an ubiquitous fungus. Its prevalence in healthy human oral cavities, according to Western studies, ranges from 40% to 60%. However, when appropriate conditions such as local or systemic deficiencies in the host defenses supervene they multiply creating multiple pathologies. In the oral cavity these can be divided into a triad of entities now known as erythematous, pseudomembranous and hyperplasic variants. Despite its importance as a sentinel opportunistic infection in diseases, such as the human immunodeficiency virus (HIV), little is known about the major etiological agent of oral candidiasis (syn=candi-dosis) -Candida albicans (C.albicans), or other Candida species, especially in Asian cohorts (Samaranayake and MacFralane, 1990) . Thus, for a prolonged period oral candidal prevalence in humans was documented essentially using data from studies conducted in the West and their prevalence in inhabitants in different regions of the world was not known.
In one of the earliest studies from Asia, Sedgley and Samaranayake (1994) found using saline oral rinse samples, in 300 community-dwelling Hong Kong Chinese attending an outpatient dental clinic, the oral prevalence of yeasts to be 24%, with C. albicans forming 77% of all yeasts isolated. However, subjects taking medication or wearing dentures had a significantly higher oral yeast prevalence of 36.8% and 44.7%, respectively, as well as those who were over 50 years of age. Comparisons of these and previous Western studies suggested that the oral prevalence of yeasts in health to be notably lower in this Southern Chinese population. In another, 4-year longitudinal study in 116 Chinese primary school children in Hong Kong Sedgley et al. (1997) noted the oral prevalence of yeasts for each consecutive year to be 7.7%, 12.0%, 14.4% and 15.5%, respectively, with a weighted mean of 12.5%. C.albicans comprised 84% of all yeasts isolated. Repeated isolation of Candida species from individual children over the 4-year study period was rare, suggesting that candidal carriage of these organisms is transient and perhaps lower than from the Western populations.
These intriguing data on yeast carriage in healthy mouths which differed from the traditional norms have led a few workers to explore this area further. These findings from Hong Kong, Thailand, and Cambodia in HIV-infected individuals, leprosy patients and betel chewers provide us with a fascinating glimpse of the clinical epidemiology of an ubiquitous fungus which we know so little about. In this mini review the data from Asian studies on oral carriage of Candida in a number of Asian cohorts are provided.
HIV infected individuals and oral yeast carriage
Almost all patients with HIV infection develop oral candidiasis at some point during the progression of the infection to acquired immunodeficiency syndrome (AIDS). In the early stages of HIV infection, the development of oral candidiasis is highly predictive of worsening immunodeficiency. Hence many have attemptted to sequentially follow the different communities or clades or families of Candida residing inside the mouth and how they behave when the host progresses from symptomless HIV infection to full blown AIDS. These early studies attempting to characterize C. albicans into different subtypes or clades used rather primitive biotyping methods that are currently superseded by various genotyping techniques.
In a landmark study, oral C.albicans isolates from HIV-infected individuals from Hong Kong, Australia, Germany and England were characterized using such a biotyping system. A total of 33 isolates from Hong Kong, 37 from Australia, 30 from Germany, and 17 from England were characterized using a biotyping system based upon enzyme profiles, carbohydrate assimilation patterns, and boric acid resistance of the yeasts (Tsang et al., 1995) . A total of 44 biotypes were identified, and A1R and A1S were the two major biotypes, accounting for 17.9% and 11.1% of all isolates, respectively. A few biotypes were unique to individual countries. These workers, therefore, concluded that many different sub-strains of C.albicans persist in HIV-infected patients, most of which are globally prevalent.
A similar study was conducted in Cambodia by the same group of workers to determine the prevalence of Candida species in HIV-infected Cambodians with oral candidiasis and either unexposed (groupⅠ) or exposed to antimycotics (groupⅡ), together with a healthy control population (group Ⅲ). In 161 HIV patients with oral candidiasis (groupⅠ: 121 pts; groupⅡ: 40 pts) and in 81 controls (group Ⅲ) swab samples of tongue and palate were obtained (Schmidt-Westhausen et al., 2004) . Oral candidiasis was detected in 100% and 70% of groupsⅠand Ⅱ, respectively. Candida species were isolated from 91% and 100% of groupsⅠand Ⅱ, respectively, and from 79% of controls. C.albicans was the most common, with non-albicans species such as Candida tropicalis (C.tropicalis) and Candida krusei (C.krusei) being notable isolates. The data further indicated that variants of oral candidal infections in HIV disease are similar to those seen in the pre-HAART era and, a very high isolation rate of C.krusei in all three groups.
Candida krusei and leprosy patients
Although C.albicans is the most common human yeast pathogen, other Candida species such as C.krusei are now recognized as emerging agents, especially in patients with HIV disease. C.krusei is intrinsically resistant to the widely used triazole antifungal fluconazole and poses therapeutic problems, especially in systemic candidiasis. pursued the thread of high isolation rates of C.krusei in HIV-infected patients in Cambodia and further extended their studies into a relatively neglected patient cohort in Thailand. Thus, in a surveillance study of leprosy patients (with arrested or burnt-out disease) in a leprosarium in northern Thailand, they found the oral carriage of C.krusei (36%) significantly (P< 0.05) higher than that in a healthy control group (10%). Among the Candida-positive patients, 16 of 35 (46%) carried C.krusei and, surprisingly, C.albicans was the second most common isolate (12 of 35 patients; 34%). The corresponding figures for the control group were 2 of 13 (15%) and 6 of 13 (46%), respectively.
Studies of the antifungal resistance of the C. krusei isolates from patients indicated that all except one of the isolates were resistant to fluco-nazole, two isolates were resistant to ketoconazole, and all isolates were sensitive to amphotericin B. Evaluation of their genetic profiles by randomly amplified polymorphic DNA analysis with three different primers and subsequent analysis of the gel profiles by computerized cluster-derived dendrograms revealed that the C.krusei isolates from patients belonged to 10 disparate clusters, despite the origin from a single locale. These nascent findings indicated an alarmingly high prevalence of a Candida species resistant to a widely used antifungal in a part of the globe where HIV disease is endemic.
These seminal data provided a tantalizing glimpse of the oral mycotic flora in an, as yet, undescribed patient population. Most importantly, the findings revealed the high prevalence of C.krusei in the cohort and the intriguingly divergent genomic profiles of these strains. In biological terms, the prolific diversity of such a relatively innocuous opportunistic pathogen, which usually resides in ripe exotic fruits, is surprising and warrants further study.
The authors further surmised that in view of the predominance of a triazole-resistant C.krusei strain in this population and the high prevalence and incidence of HIV infection in northern Thailand, which in turn predisposes individuals to candidiasis, similar prevalence studies should be pursued with other regional population groups. If such data indicate a predominance of this yeast in the general populace, this may have implications for the protocols guiding the management of HIVrelated candidiasis, in which fluconazole is the drug of choice.
Betel quid chewing and Candida
Betel quid chewing (BQC), a very popular habit in many Asian countries has been studied and well documented by Reichart and Philipsen (1996) in their unique tome. Hence, it is not surprising that they investigated the effect of BQC on the oral carriage of Candida and attendant mucosal pathology. In an as of yet unrepeated sentinel study they investigated the effect of BQC, on the oral carriage of Candida species in 48 Cambodian women with BQC habit and 13 control subjects without the habit. In addition, the lesions of the oral mucosa likely to be associated with BQC habit were assessed . In individuals with a median duration of BQC of 10 years they noted, betel chewer's mucosa (85.4%), oral leukoplakia (8.3%), leukoedema (37.5%) and oral lichen planus (4.2%). Oral candidiasis was seen neither in BQ chewers nor in controls. Candida species were found in 70.8% of the cases (controls 69.2%). C.albicans was isolated from 27.1% of the study cohort, C.tropicalis was the second most common isolate. One control case was colonized by Candida dubliniensis (C. dubliniensis) -the first report of this organism from a Cambodian population. There was no significant difference in the candidal carriage rate or the Candida species isolated between the study and the control group. Hence the authors concluded that BQC has no significant impact on oral colonization by Candida species.
In an identical study in northern Thailand the same workers obtained oral swabs from the tongue and palate of 50 Padaung women with and 50 control individuals without BQC habit (Reichart et al., 2005) (Figure 1 ). The mean age of BQ chewers was 35.4 years, of non-chewers was 19.2 years. C.parapsilosis was the most common Candida species isolated both in BQ chewers (46%) and non-chewers (44%) and C.albicans in 24% of BQ chewers and 18% of non-chewers. There was no significant difference in carriage of Candida species isolated between both groups. 44% of BQ chewers revealed betel chewers mucosa and 10% showed leukoedema (Figure 2 ). 
